Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on H. Pylori Eradication with Esomeprazole Triple Therapy
NCT02552641Phase 4Withdrawn
- Sponsor
- EMS
- Start
- Sep 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esomeprazole, amoxicillin and clarithromycin in Helicobacter pylori infection (3 arms), sponsored by EMS. Primary endpoint: Rate of H pylori eradication at 7 days. Planned start Sep 2015; status: withdrawn.
02
Drugs
esomeprazoleamoxicillinclarithromycin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02552641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02552641.